Hormonal manipulation of prostatic cancer.
- 14 December 1991
- Vol. 303 (6816) , 1489-1490
- https://doi.org/10.1136/bmj.303.6816.1489
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Orchiectomy versus Oestrogen in the Treatment of Advanced Prostatic CancerBritish Journal of Urology, 1991
- A Controlled Trial of Castration With and Without Nilutamide in Metastatic Prostatic CarcinomaCancer, 1990
- Zoladex and Flutamide Versus Orchiectomy in the Treatment of Advanced Prostatic CancerCancer, 1990
- A Controlled Trial of Leuprolide with and without Flutamide in Prostatic CarcinomaNew England Journal of Medicine, 1989
- Low Androgen Levels Induce the Development of Androgen-Hypersensitive Cell Clones in Shionogi Mouse Mammary Carcinoma Cells in CultureJNCI Journal of the National Cancer Institute, 1988
- Importance of early tumour exacerbation in patients treated with long acting analogues of gonadotrophin releasing hormone for advanced prostatic cancer.BMJ, 1985
- Comparison of Prostatic Cancer Tissue Dihydrotestosterone Levels at the Time of Relapse Following Orchiectomy or Estrogen TherapyJournal of Urology, 1984
- New approach in the treatment of prostate cancer: Complete instead of partial withdrawal of androgensThe Prostate, 1983
- Prostatic Carcinoma Cured with Hormonal TreatmentScandinavian Journal of Urology and Nephrology, 1981
- Long-term Survival after Hormonal Therapy for Stage D Prostatic CancerJournal of Urology, 1979